Sign in

CIK 0000874716

  • Large accelerated filer

IDEXX LABORATORIES INC /DE

Sign in to watch
Ticker
IDXX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010393723
Phone
+1 207-556-0300
Business address
ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 512 shares at an average $541.02 ($277,000)
  4. 4 Grant or award Director acquired 11 shares (grant or award)
  5. 4 Grant or award Director acquired 36 shares (grant or award)
  6. 4 Grant or award Director acquired 36 shares (grant or award)
  7. 4 Exercise or conversion Senior Vice President acquired 3,227 shares (option exercise)
  8. 4 Exercise or conversion Executive Vice President acquired 1,476 shares (option exercise)
  9. 4 Open-market sale Director sold 3,046 shares at $513.41 ($1,563,840)
  10. 4 Exercise or conversion Director acquired 1,476 shares (option exercise)
  11. 4 Exercise or conversion SVP, Gen. Counsel & Secretary acquired 483 shares (option exercise)
  12. 4 Exercise or conversion President & CEO acquired 1,475 shares (option exercise)
  13. 4 Open-market sale Director sold 1,898 shares at an average $538.57 ($1,022,207)
  14. 4 Open-market sale Director sold 1,000 shares at $555.56 ($555,561)
  15. 4 Exercise or conversion Executive VP & CFO acquired 1,474 shares (option exercise)
  16. 4 Open-market sale President & CEO sold 13,868 shares at an average $537.21 ($7,449,969)
  17. 4 Open-market sale Director sold 7,331 shares at an average $536.91 ($3,936,089)
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 74 · 1,467 filings